thiazoles has been researched along with Left Ventricular Dysfunction in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, H; Castillero, E; George, I; Homma, S; Ji, R; Kennel, PJ; Schulze, PC; Zizola, C | 1 |
| Myers, RB; Yoshioka, J | 1 |
| Bache, RJ; Chen, Y; Hu, X; Lu, Z; Wessale, JL; Xu, X; Zhang, P; Zhao, L | 1 |
| Ahluwalia, MS; Battiwalla, M; Cohen, IL; Francis, J; McCarthy, PL; Paplham, P; Smiley, S; Spangenthal, E; Wang, E; Wetzler, M | 1 |
| Egashira, K; Hayashidani, S; Ikeuchi, M; Ishibashi, M; Kubota, T; Shiomi, T; Suematsu, N; Takeshita, A; Tsutsui, H; Wen, J | 1 |
| Gen, M; Greyson, C; Kinugawa, K; Lee, J; Long, CS; Lu, L; Schwartz, GG; Xu, Y | 1 |
| Degroof, RC; Hundley, WG; Kitzman, DW; Little, WC; O'Brien, TX; Zile, MR | 1 |
| Redfield, MM | 1 |
| Goddard, CM; Leaf, CD; Poon, BY; Russell, JA; Walley, KR | 1 |
| Cheng, XS; Egashira, K; Fukuyama, N; Momii, H; Nakazawa, H; Oyama, J; Shimokawa, H; Takeshita, A | 1 |
| Kohno, M; Miyatake, A; Mizushige, K; Murakami, K; Noma, T; Ohmori, K; Tsuji, T | 1 |
| Poloński, L; Sidorowicz, K; Tkacz, E | 1 |
1 review(s) available for thiazoles and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Treating diastolic heart failure with AGE crosslink breakers: thinking outside the heart failure box.
Topics: Animals; Clinical Trials as Topic; Collagen; Drug Evaluation, Preclinical; Glycation End Products, Advanced; Heart Failure; Humans; Thiazoles; Ventricular Dysfunction, Left | 2005 |
1 trial(s) available for thiazoles and Left Ventricular Dysfunction
| Article | Year |
|---|---|
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.
Topics: Aged; Aorta; Blood Flow Velocity; Blood Pressure; Echocardiography; Exercise Test; Female; Glycation End Products, Advanced; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Oxygen Consumption; Prospective Studies; Quality of Life; Surveys and Questionnaires; Thiazoles; Ventricular Dysfunction, Left | 2005 |
10 other study(ies) available for thiazoles and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.
Topics: Adenosine Triphosphate; Animals; Cell Line; Disease Models, Animal; Energy Metabolism; Exercise Tolerance; Fatty Acids; Heart Failure; Mice, Inbred C57BL; Muscle Strength; Muscle, Skeletal; Myocardial Infarction; Oxidation-Reduction; Physical Endurance; PPAR gamma; Signal Transduction; Thiazoles; Time Factors; Transcription, Genetic; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure.
Topics: Animals; Energy Metabolism; Muscle, Skeletal; Myocardial Infarction; Physical Endurance; PPAR gamma; Thiazoles; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice.
Topics: Animals; Disease Models, Animal; Febuxostat; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Systole; Thiazoles; Ventricular Dysfunction, Left | 2008 |
Reversible cardiotoxicity with tyrosine kinase inhibitors.
Topics: Adult; Benzamides; Cardiotoxins; Central Nervous System Neoplasms; Dasatinib; Fatal Outcome; Female; Humans; Imatinib Mesylate; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Ventricular Dysfunction, Left | 2010 |
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Blood Glucose; Cytokines; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Echocardiography; Gene Expression; Heart Failure; Heart Ventricles; Hemodynamics; Male; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Observer Variation; Organ Size; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Reproducibility of Results; RNA, Messenger; Survival Rate; Thiazoles; Thiazolidinediones; Transcription Factors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2002 |
Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Chromans; Disease Models, Animal; Gene Expression Regulation; Heart; Hypoglycemic Agents; Myocardial Ischemia; Myocardial Reperfusion Injury; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Swine; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Ventricular Dysfunction, Left | 2003 |
L-2-Oxothiazolidine-4-carboxylic acid prevents endotoxin-induced cardiac dysfunction.
Topics: Analysis of Variance; Animals; Endotoxins; Escherichia coli; Free Radicals; Glutathione; Infusions, Intravenous; Injections, Subcutaneous; Leukocyte Count; Myocardial Contraction; Myocardium; Prodrugs; Pyrrolidonecarboxylic Acid; Rabbits; Reactive Oxygen Species; Thiazoles; Thiazolidines; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left | 1998 |
Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo.
Topics: Analysis of Variance; Animals; Antioxidants; Biomarkers; Dogs; Echocardiography; Female; Interleukin-1; Male; Myocardium; Nitrates; Random Allocation; Stroke Volume; Superoxides; Thiazoles; Tyrosine; Ventricular Dysfunction, Left | 1999 |
Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat.
Topics: Animals; Blood Glucose; Collagen; Diabetes Mellitus, Type 2; Diastole; Echocardiography, Doppler; Hemodynamics; Hypoglycemic Agents; Insulin; Kinetics; Lipids; Male; Malondialdehyde; Oxidative Stress; Pioglitazone; Prediabetic State; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Thiazoles; Thiazolidinediones; Thiobarbituric Acid Reactive Substances; Ventricular Dysfunction, Left | 2001 |
[Influence of therapy schedule on hospitalization frequency and prognosis in heart failure in 3 yrs. observations].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Drug Administration Schedule; Female; Hospitalization; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Prognosis; Retrospective Studies; Survival Analysis; Thiazoles; Ventricular Dysfunction, Left | 2002 |